| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/14/2002 | WO2002012274A2 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | WO2002012268A1 Motor proteins and methods for their use |
| 02/14/2002 | WO2002012263A1 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
| 02/14/2002 | WO2002012262A1 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
| 02/14/2002 | WO2002011886A2 Apparatus for diagnostic assays |
| 02/14/2002 | WO2001098471A8 Human phosphodiesterases |
| 02/14/2002 | WO2001081896B1 An ultra-fast nucleic acid sequencing device and a method for making and using the same |
| 02/14/2002 | WO2001077128A3 Haplotypes of the slc5a3 gene |
| 02/14/2002 | WO2001075139A8 Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization |
| 02/14/2002 | WO2001072965A3 Haplotypes of the fkbp8 gene |
| 02/14/2002 | WO2001072838A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/14/2002 | WO2001072328A3 Methods of treating diseases with activated protein c |
| 02/14/2002 | WO2001068670A3 Family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof |
| 02/14/2002 | WO2001066800A8 Human single nucleotide polymorphisms |
| 02/14/2002 | WO2001064874A3 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/14/2002 | WO2001064835A8 Novel nucleic acids and polypeptides |
| 02/14/2002 | WO2001064834A8 Novel nucleic acids and polypeptides |
| 02/14/2002 | WO2001062954A8 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 02/14/2002 | WO2001059163A3 Method for detecting and quantifying adenovirus |
| 02/14/2002 | WO2001059120A3 Il-17 like molecules and uses thereof |
| 02/14/2002 | WO2001059096A9 Method of detecting ligand or ligand-like low-molecular weight compound |
| 02/14/2002 | WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 02/14/2002 | WO2001057248A3 Polynucleotide arrays and their use in sequencing |
| 02/14/2002 | WO2001057236A3 Process for detecting modulation of nad(p)h oxidoreductase |
| 02/14/2002 | WO2001055346A3 System for the internal qualitative and quantitative validation of marker indices |
| 02/14/2002 | WO2001055302A3 Nucleic acids, proteins, and antibodies |
| 02/14/2002 | WO2001054814A3 Compositions and methods for performing biological reactions |
| 02/14/2002 | WO2001051619A3 Genetically modified fibroblast cell |
| 02/14/2002 | WO2001048249A3 Recombinase mediated gene chip detection |
| 02/14/2002 | WO2001048237A3 Method for quickly detecting microbial dna/rna, kit therefor and the use of said method |
| 02/14/2002 | WO2001046460A3 Method for analyzing nucleic acid sequences |
| 02/14/2002 | WO2001046457A3 Amperometric biosensor test strip |
| 02/14/2002 | WO2001044502A3 Genetic variants of the human fsh receptor and the influence thereof on gametogenesis |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001040765A3 Improved flow cytometer nozzle and flow cytometer sample handling methods |
| 02/14/2002 | WO2001038579A3 Method of identifying toxic agents using nsaid-induced differential gene expression in liver |
| 02/14/2002 | WO2001038362A3 Production of vaccines |
| 02/14/2002 | WO2001037852A3 Methods of inhibiting atrophy or promoting hypertrophy |
| 02/14/2002 | WO2001036680A3 METHODS OF PREPARING cRNA |
| 02/14/2002 | WO2001036589A3 Human ex vivo immune system |
| 02/14/2002 | WO2001032828A3 Biological fluid processing |
| 02/14/2002 | WO2001025489A3 Diagnostic and therapeutic uses for a gene differentially expressed in prostate cancer |
| 02/14/2002 | WO2001021771A3 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 02/14/2002 | WO2001020329A3 Test systems and sensors for detecting molecular binding events |
| 02/14/2002 | WO2000065062A3 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 02/14/2002 | WO2000053810A3 Gene chip technology for determining memory genes |
| 02/14/2002 | WO2000046366A9 Isolation of nucleic acid molecules |
| 02/14/2002 | US20020019994 Classification of plants; obtain plant, isolate amylase, monitor amylase for heat resistance, classify plant |
| 02/14/2002 | US20020019704 Significance analysis of microarrays |
| 02/14/2002 | US20020019522 Steroids |
| 02/14/2002 | US20020019518 A sublancin peptide variant (lantibody) having a spacer region and a subtilin leader peptide to provide an anchoring means for inserting and retaining the lantibody in a host cell wall; genetic engineering; bactericides; viricides; kits |
| 02/14/2002 | US20020019517 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 02/14/2002 | US20020019515 Novel spoIIIE |
| 02/14/2002 | US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis |
| 02/14/2002 | US20020019378 Compounds |
| 02/14/2002 | US20020019359 Oligonucleotide with a base sequence complementary to a target portion of a nucleic acid encoding angiogenin |
| 02/14/2002 | US20020019330 Screening drug candidates comprising providing a cell that expresses an expression profile gene encoding a protein (AAA9) or fragment, adding a drug candidate to the cell, determining the effect of the drug candidate |
| 02/14/2002 | US20020019046 Generating preferential aggregations; prepare suspension of stem cells, plate on solid surface, harvest aggregations |
| 02/14/2002 | US20020019029 Protein; for use in the treatment of cancer, cardiovascular disorders and nervous system disorders |
| 02/14/2002 | US20020019028 Peptide; for use in the treatment of defects associated with polypeptide transfer |
| 02/14/2002 | US20020019024 Cell activity assay apparatus and methods for making and using same |
| 02/14/2002 | US20020019023 Monitoring patterns of biopolymers; obtain sample, expose to modulator, compare to control, evaluate ajustments |
| 02/14/2002 | US20020019021 Evaluating anticoagulants; obtain sample, incubate with prothrobin activator, monitor and measure thrombin formation |
| 02/14/2002 | US20020019012 Method and apparatus for predicting a signal peptide cleavage site |
| 02/14/2002 | US20020019011 Mixture of therapeutic particles for use in the treatment of aging, viral, genetic and cancer diseases |
| 02/14/2002 | US20020019010 Treating aging, viral, genetic and cancer diseases in humans; provide therapeutic particles, generate layout, provide test sample, incubate with sample, monitor sample for reduction in injury associated with defect |
| 02/14/2002 | US20020019007 Nucleotide sequences for use as diagnostic tools in detection of preferential microorganism |
| 02/14/2002 | US20020019005 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
| 02/14/2002 | US20020019003 Method for the targeted application of reagents onto immobilized biological material |
| 02/14/2002 | US20020019001 Method of detecting single gene copies in-situ |
| 02/14/2002 | US20020019000 Polynucleotides coexpressed with matrix-remodeling genes |
| 02/14/2002 | US20020018999 Methods for characterizing polymorphisms |
| 02/14/2002 | US20020018998 System for simple nucleic acid analysis |
| 02/14/2002 | US20020018997 Detecting modulators of protein binding activity; obtain sample, incubate with modulators and proteins, monitor activity of binding proteins |
| 02/14/2002 | US20020018996 Nucleotide sequences for use as tools in screening, isolation and separtion of preferential nucleotide sequences |
| 02/14/2002 | US20020018995 Detecting brain disorders; obtain sample tissue, monitor tau mutant isoform duplications in cell, compare to wild type, amplification in tau mutant isoforms indicates brain disorders |
| 02/14/2002 | US20020018994 Continuous in vitro evolution of oligonucleotides |
| 02/14/2002 | US20020018993 Nucleotide sequences for use as tools in mapping bird chromosomes |
| 02/14/2002 | US20020018992 Detecting nucleotide sequences coding preferential polypeptides; provide cells, transform with expression vectors, detect expression from reporter molecules, recover cells expressing preferential gene |
| 02/14/2002 | US20020018991 A biological chip plate with plurality of test wells, each test well having a biological chip having a molecular probe array; introducing samples into the well, manipulating chip plate by fluid handling device for automatic performance step |
| 02/14/2002 | US20020018990 Reagents and methods useful for detecting diseases of the breast |
| 02/14/2002 | US20020018989 Method of identifying pharmaceuticals from plant extracts |
| 02/14/2002 | US20020018988 In silico screening |
| 02/14/2002 | US20020018843 Detection of biological molecules using chemical amplification and optical sensors |
| 02/14/2002 | US20020018769 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 02/14/2002 | US20020018766 Genes differentially expressed in cancer cells to design cancer vaccines |
| 02/14/2002 | US20020018765 Genetic engineering; transforming genes; Dna viruses |
| 02/14/2002 | US20020018199 Imaging of biological samples using electronic light detector |
| 02/14/2002 | DE10038237A1 Verfahren zum Nachweis von Mutationen in Nucleotidsequenzen A method for detecting mutations in nucleotide sequences |
| 02/14/2002 | DE10037506A1 Verfahren zum Nachweis von Nukleinsäuren mittels Hybridisierung, Verwendung dieses Verfahrens und entsprechender Analysekit sowie Nukleinsäure-Oligomere und deren Verwendung A method for detecting nucleic acids by means of hybridization using this method and a corresponding analysis kit and nucleic acid oligomers and their use |
| 02/14/2002 | DE10036501A1 Verfahren zur Messung der JNK/SAPKs-Aktivität mittels der Bestimmung der Phosphorylierung von Transkriptionsfaktoren Method for measuring the JNK / SAPKs activity by determining the phosphorylation of transcription factors |
| 02/14/2002 | DE10036486A1 Verfahren zur Auftrennung von in Lösung befindlichen doppelstränigen Nukleinsäuren in einzelsträngige Nukleinsäuren Method for the separation of double-stranded nucleic acids in solution in single stranded nucleic acids |
| 02/14/2002 | DE10036457A1 Verwendung eines bildgebenden photoelektrischen Flächensensors zur Auswertung von Biochips und Bildgebungsverfahren hierfür Use of an imaging photoelectric area sensor for evaluation of biochips and imaging method therefor |
| 02/14/2002 | DE10015547C2 Verfahren zur Detektion von Molekülen mittels Impedanzspektroskopie und Vorrichtung zur Durchführung dieser Verfahren A method for detecting molecules by means of impedance spectroscopy and apparatus for performing these methods |
| 02/14/2002 | CA2569615A1 Nucleic acid binding compounds containing pyrazolo[3,4-d] pyrimidine analogues of purin-2,6-diamine and their uses |
| 02/14/2002 | CA2453907A1 Association of sim2 with cancer |
| 02/14/2002 | CA2422803A1 Detection of cox-2 activity and anandamide metabolites |
| 02/14/2002 | CA2422306A1 Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites |
| 02/14/2002 | CA2419064A1 Kruppel-like factor 6 (klf6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein |
| 02/14/2002 | CA2419062A1 Methods for culturing human lung mast cells and uses thereof |